Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Protein Folding01:22

Protein Folding

Overview
Protein Folding01:25

Protein Folding

Proteins are chains of amino acids linked together by peptide bonds. Upon synthesis, a protein folds into a three-dimensional conformation, critical to its biological function. Interactions between its constituent amino acids guide protein folding, and hence the protein structure is primarily dependent on its amino acid sequence.
Protein Structure Is Critical to Its Biological Function
Proteins perform a wide range of biological functions such as catalyzing chemical reactions, providing...
Cooperative Allosteric Transitions01:58

Cooperative Allosteric Transitions

Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Vitronectin metabolically programs profibrotic macrophages in 3D cultures and idiopathic pulmonary fibrosis.

Science advances·2026
Same author

Co-culture with fibroblasts in stiff 3D scaffolds increases CD54 and CD140a expression on macrophages.

Frontiers in immunology·2026
Same author

The dynamic and heterogeneous structure of the non-canonical inflammasome.

bioRxiv : the preprint server for biology·2026
Same author

Intramolecular loops control SARS-CoV-2 nucleocapsid protein self-association and nucleic acid binding dependent on phosphorylation.

bioRxiv : the preprint server for biology·2026
Same author

Evolution of a fuzzy ribonucleoprotein complex in viral assembly.

eLife·2025
Same author

Mechanism of NanR transcriptional activation of sialic acid metabolism in <i>Streptococcus pneumoniae</i>.

bioRxiv : the preprint server for biology·2025

Related Experiment Video

Updated: May 24, 2026

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
08:53

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids

Published on: March 21, 2025

An equilibrium model for linear and closed-loop amyloid fibril formation.

Shuo Yang1, Michael D W Griffin, Katrina J Binger

  • 1Department of Biochemistry and Molecular Biology, Bio21 Molecular Science and Biotechnology Institute, University of Melbourne, Victoria 3010, Australia.

Journal of Molecular Biology
|February 29, 2012
PubMed
Summary

Human apolipoprotein C-II forms reversible amyloid fibrils through a self-assembly process. A new model explains fibril size distribution and closed-loop formation, offering insights into age-related disease mechanisms.

More Related Videos

Analysis of &#946;-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

Related Experiment Videos

Last Updated: May 24, 2026

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids
08:53

Characterization of pH-Dependent Reversible Self-Assembly of Amyloid Beta 1-40-Coated Gold Colloids

Published on: March 21, 2025

Analysis of &#946;-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
06:27

Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy

Published on: November 30, 2018

Area of Science:

  • Biochemistry
  • Structural Biology
  • Biophysics

Background:

  • Amyloid fibrils and oligomers are linked to neurodegenerative diseases like Alzheimer's and Parkinson's.
  • Fibril assembly pathways influence oligomer/fibril distribution and toxicity.
  • Human apolipoprotein C-II (apoC-II) forms amyloid fibrils via a reversible process involving closed-loop formation and fibril dynamics.

Purpose of the Study:

  • To investigate the reversible self-assembly mechanism of human apoC-II amyloid fibrils.
  • To develop a thermodynamic model explaining fibril size distribution and closed-loop formation.
  • To elucidate the role of monomer isomerization and fibril dynamics in apoC-II fibrillogenesis.

Main Methods:

  • Fluorescence quenching and sedimentation velocity experiments with Alexa488-labeled apoC-II.
  • Dilution experiments with mature apoC-II fibrils.
  • Development and application of an equilibrium self-association model incorporating isomerization, self-assembly, and fibril dynamics.

Main Results:

  • Demonstrated time-dependent subunit interchange in both linear and closed-loop apoC-II fibrils.
  • Dilution experiments confirmed a reversible assembly pathway with shifts to smaller size distributions.
  • The developed model accurately described apoC-II fibril size distributions and closed-loop formation across varying concentrations (0.1-0.5 mg/ml).
  • Kinetic data on fibril formation and size changes were well-explained by the extended model.

Conclusions:

  • ApoC-II fibril formation is governed by a reversible self-assembly pathway involving monomer isomerization and isodesmic self-association.
  • Fibril length-dependent closed-loop formation is a key feature of apoC-II fibrillogenesis.
  • The model provides a thermodynamic framework for understanding apoC-II fibril equilibrium and the formation of oligomeric intermediates, relevant to age-related diseases.